Company



The company was founded as a service business in the area of molecular biology with the original objective of becoming active primarily on the market of recombinantly produced proteins. Over time this range has shifted, due to customer demands, into the area of molecular diagnostics and gene expression analysis. An additional core area is the cloning of specific DNA fragments and their sequencing.

GenExpress is located in the same building as TIB Molbiol Syntheselabor GmbH and works at times as a subcontractor or by direct order for TIB Molbiol.

The company operated successfully in four concluded joint research projects.
1. The generation of therapeutically applicable T cells in bone marrow transplantation (BMBF-funded) ... continue >>
2. The development of a skin bioreactor using stem cells from the hair follicle (BMBF-funded) ... continue >>
3. The analysis of protein-protein interactions in yeast (EU-funded) ... continue >>
4. Design and establishment of diagnostically relevant PCR systems and cloning of the positive controls (EU-funded) ... continue >>
At this time GenExpress is participating in another joint research project. In the BMBF-funded joint project BIGRUDI (Biological vulnerabilities: Risk evaluation, ultra-fast detection and identification of agents relevant in terms of bio terrorism) which is coordinated through the Robert Koch Institut we produce recombinant proteins and toxins for diagnostics.

The participation in these joint research projects continuously enhanced GenExpress's public profile and allowed us to win new customers.
However, in addition to these research participations direct processing of individual customer orders remains at the core of our activities. The cloning of human cDNA fragments was performed in close cooperation with the molecular biology department of the German Rheuma-tism Research Center (Deutsches Rheuma-Forschungszentrum). But we also executed larger projects in the areas of genome walking, analysis of expression banks and production of specific probes for in situ hybridization. A particular focus is on the creation of positive controls and internal standards for real-time PCR.
So far the extensive know-how of our staff allowed us to execute all orders to the satisfaction of our customers. This means that customer satisfaction is our top priority. Even if an order turns out to be unprofitable.

As a pure service business GenExpress continuously incorporates special customer requirements. Ultimately, every product is individual contract work.

GenExpress advises their customers in the execution of the desired tasks. This is usually done through the creation of an individual offer as a reaction to an enquiry. In this we often present alternative ways, offered with separate pricing. We also discuss the respective experimental approaches in order to find new solutions and to locate errors and problems.

The quality management system implemented since the year 2003 stabilizes the status of the company reached so far and at the same time contributes to the continuous improvement of our services for our customers, thus improving customer satisfaction on a continuous and sus-tained basis.

News

18.03.2011

GenExpress website now also available in English.

06.01.2011

In December 2010 GenExpress successfully passed the recertification audit in compliance with ISO 9001:2008. The new certificates are available for download.

02.07.2010

GenExpress launches new website.

30.04.2010

Successful conclusion of the EU-funded USDEP project.  continue >>